Genomed Spólka Akcyjna (WSE:GEN)

Genomed Spólka Akcyjna Statistics

Total Valuation

WSE:GEN has a market cap or net worth of PLN 36.47 million. The enterprise value is 30.35 million.

Market Cap	36.47M
Enterprise Value	30.35M

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

WSE:GEN has 1.32 million shares outstanding.

Current Share Class	648,283
Shares Outstanding	1.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.76%
Owned by Institutions (%)	n/a
Float	41,650

Valuation Ratios

The trailing PE ratio is 10.86.

PE Ratio	10.86
Forward PE	n/a
PS Ratio	1.25
PB Ratio	2.59
P/TBV Ratio	2.60
P/FCF Ratio	18.41
P/OCF Ratio	10.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.22, with an EV/FCF ratio of 15.32.

EV / Earnings	9.04
EV / Sales	1.04
EV / EBITDA	6.22
EV / EBIT	7.37
EV / FCF	15.32

Financial Position

The company has a current ratio of 5.61

Current Ratio	5.61
Quick Ratio	4.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	7,984.78

Financial Efficiency

Return on equity (ROE) is 27.09% and return on invested capital (ROIC) is 46.64%.

Return on Equity (ROE)	27.09%
Return on Assets (ROA)	17.82%
Return on Invested Capital (ROIC)	46.64%
Return on Capital Employed (ROCE)	28.52%
Weighted Average Cost of Capital (WACC)	4.27%
Revenue Per Employee	549,469
Profits Per Employee	63,367
Employee Count	53
Asset Turnover	2.02
Inventory Turnover	4.69

Taxes

In the past 12 months, WSE:GEN has paid 770,179 in taxes.

Income Tax	770,179
Effective Tax Rate	18.65%

Stock Price Statistics

The stock price has increased by +10.40% in the last 52 weeks. The beta is 0.00, so WSE:GEN's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	+10.40%
50-Day Moving Average	28.61
200-Day Moving Average	27.02
Relative Strength Index (RSI)	47.96
Average Volume (20 Days)	419

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:GEN had revenue of PLN 29.12 million and earned 3.36 million in profits. Earnings per share was 2.54.

Revenue	29.12M
Gross Profit	19.33M
Operating Income	4.12M
Pretax Income	4.13M
Net Income	3.36M
EBITDA	4.88M
EBIT	4.12M
Earnings Per Share (EPS)	2.54

Balance Sheet

The company has 6.12 million in cash and n/a in debt, with a net cash position of 6.12 million or 4.63 per share.

Cash & Cash Equivalents	6.12M
Total Debt	n/a
Net Cash	6.12M
Net Cash Per Share	4.63
Equity (Book Value)	14.08M
Book Value Per Share	10.65
Working Capital	9.47M

Cash Flow

In the last 12 months, operating cash flow was 3.41 million and capital expenditures -1.43 million, giving a free cash flow of 1.98 million.

Operating Cash Flow	3.41M
Capital Expenditures	-1.43M
Free Cash Flow	1.98M
FCF Per Share	1.50

Margins

Gross margin is 66.36%, with operating and profit margins of 14.15% and 11.53%.

Gross Margin	66.36%
Operating Margin	14.15%
Pretax Margin	14.18%
Profit Margin	11.53%
EBITDA Margin	16.75%
EBIT Margin	14.15%
FCF Margin	6.80%

Dividends & Yields

WSE:GEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	9.21%
FCF Yield	5.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5